Our Solutions

At Everlume, we know firsthand the urgency and frustration that comes with navigating a rare disease diagnosis. Our Direct-to-Patient Cure Plan is designed to guide families through each step of the drug discovery process, offering a clear, actionable pathway to develop personalized treatments.

Customized Therapeutic Development

We leverage cutting-edge genetic insights and technologies to design therapies that are personalized to your loved one’s condition. Whether it’s identifying the root genetic cause or advancing a treatment to clinical trials, we work swiftly to ensure the best possible outcomes.

Expert Guidance and Support

Our team of scientists and drug development experts are here to provide continuous support, guiding families through the complexities of research, clinical trials, and regulatory hurdles.

N=1 Clinical Trials

For diseases that affect a single patient or very small populations, we can rapidly initiate personalized N=1 trials, bringing potential treatments to patients far faster than traditional methods.

With Everlume, families have a trusted partner in their fight to find a cure.

Foundations working to advance treatments for rare diseases are vital to the progress of drug discovery, but navigating this space efficiently can be overwhelming. Everlume partners with foundations to streamline the pre-clinical research process, helping you maximize your impact.

Preclinical Strategy Development

We help foundations create clear, actionable research roadmaps, ensuring that funds are used efficiently and effectively to bring therapeutic candidates into the preclinical pipeline.

Collaboration and Resource Sharing

By working closely with academic researchers and biotech partners, we reduce duplication of efforts, enhance collaboration, and ensure that the right experts are driving each stage of development.

Accelerated Research Pathways

Leveraging Everlume’s drug development infrastructure, foundations can move from basic research to potential treatments in significantly less time, ensuring that the promise of breakthroughs can quickly become reality.

Our goal is to help foundations turn donations into treatments that make a tangible impact for patients.

Everlume is proud to partner with biotech companies to support their preclinical research efforts. With our extensive expertise in rare disease drug development and access to advanced genetic technologies, we offer services that can help biotechs streamline the discovery and development of novel therapeutics.

Preclinical Drug Development

We assist biotech companies by offering comprehensive preclinical services, including lead optimization, toxicology studies, and IND-enabling activities. Our deep expertise in genetic research ensures that your therapeutic candidates are fully vetted before entering clinical trials.

Innovative Genetic Approaches

We specialize in identifying therapeutic opportunities for rare and ultra-rare diseases using advanced technologies like gene therapy, antisense oligonucleotides, and CRISPR-based methods.

Efficient Project Management

We manage the complexities of drug development by coordinating preclinical activities, ensuring regulatory compliance, and facilitating transitions from preclinical to clinical phases efficiently.

Everlume is dedicated to helping biotech partners unlock the potential of their drug discovery efforts by providing the expertise and infrastructure needed to accelerate progress.